ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NHS lifted Imbruvica restrictions after press campaign
pharmaphorum
August 22, 2018England’s National Health Service has lifted restrictions on Janssen’s blood cancer drug Imbruvica (ibrutinib), after a journalist who was suffering from chronic lymphocytic leukaemia (CLL) was denied access.
Pharma Sources Insight January 2025
